COMPANY PROFILE / #3582
inHEART
Pessac, FranceVenture Capital-Backed
OVERVIEW
Developer of a heart imaging technology designed for personalized treatment, prevention, and screening for cardiac arrhythmias, heart failure, and stroke. The company's technology transforms preoperative medical images into a digital twin of the patient's heart, enabling cardiologists to plan the procedure and assist in navigating instruments in the patient's heart, substantially reducing procedure duration and failure rates.
已融资22.04
最新估值35.89
员工数48
成立年份2017
公司概况
- Companies
- inHEART
- Description
- Developer of a heart imaging technology designed for personalized treatment, prevention, and screening for cardiac arrhythmias, heart failure, and stroke. The company's technology transforms preoperative medical images into a digital twin of the patient's heart, enabling cardiologists to plan the procedure and assist in navigating instruments in the patient's heart, substantially reducing procedure duration and failure rates.
- Website
- www.inheartmedical.com
- HQ Location
- Pessac, France
- Year Founded
- 2017
- Keywords
- advances visualization, analysis platform, cardiac electrophysiology, cardiac imaging device, medical image analysis, medical imaging, risk analysis service
- Competitors
- Reflexion Health, Volta Medical, Riverain Technologies, AliveCor, Zebra Medical Vision, Vista.ai, Bardy Diagnostics, Ornim, HealthMyne, Virtual Radiologic, Aidoc, MedyMatch Technology, Advantis Medical Imaging, Arterys, Circle Cardiovascular Imaging, VoxelCloud, SemanticMD, AiCure, Mirada Medical, Lifetrack Medical Systems, Proteus Digital Health, Quantib
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 22.04
- First Financing Date
- 01-Jan-2017
- First Financing Size
- —
- First Financing Valuation
- —
- Last Financing Date
- 22-Aug-2026
- Last Financing Deal Type
- Secondary Transaction - Private
- Last Financing Size
- —
- Last Financing Valuation
- —
- Last Financing Status
- Completed
- Last Known Valuation
- 35.89
- Last Known Valuation Date
- 06-May-2024
- Last Known Valuation Deal Type
- Later Stage VC
- Valuation Estimate
- 40.53
- Valuation Estimate Growth Rate
- 12.91%
- Active Investors
- Aquitaine Science Transfert, Astorg, Cenitz, Cleverage Venture Capital, Elaia Partners, Inria, Nouvelle Aquitaine Co-Investissement, Sagana, Sofia Angels Ventures, SWEN Capital Partners, Tudigo, Université de Bordeaux, Vesalius Biocapital Partners, Webit Investment Network
- # Active Investors
- 14
- Acquirers
- —
团队与联系人
- Employees
- 48
- Employee Growth %
- -4.00%
- Employee History
- 2026: 48, 2025: 50, 2024: 48, 2023: 34, 2022: 26, 2021: 21, 2020: 10
- Primary Contact
- Jean-Marc Peyrat
- Primary Contact Title
- Co-Founder & Chief Innovation Officer
- Primary Contact Email
- jean-marc.peyrat@inheartmedical.com
- Primary Contact Phone
- +33 (0)5 35 38 19 72
增长与经营
- Revenue
- 2.00
- Revenue Growth %
- 174.34%
- Growth Rate
- -0.25%
- Growth Rate % Change
- —
- Growth Rate Percentile
- 10
- Size Multiple
- 5.77x
- Size Multiple % Change
- 0.00%
- Size Multiple Change
- 0.00x
- Size Multiple Percentile
- 83
- Majestic Referring Domains
- 144
- SimilarWeb Unique Visitors
- 109
- SimilarWeb Unique Visitors Change
- 15
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- —
- Success Probability Over Time – 1 Year
- 11%
- Success Probability Over Time – 3 Year
- 29%
- Success Probability Over Time – 5 Year
- 36%
记录来源：public.companies · 原始序号 #3582 · 所有字段均按数据库原值展示。